(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ATROPOS EVIDENCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ATROPOS EVIDENCE

ST13

US500000097854125

Class

9, 35, 38, 42, 44

Filing

97854125

Registration

7868580

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

07/22/2025

Trademark type

Word

Nice classes

9, 35, 38, 42, 44

Filing date

03/23/2023

Registration date

07/15/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/15/2025

Last transaction

07/22/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/10/2020

First use in commerce

12/10/2020

Drawing code

4

Owner type

03

Owner location

New York, NY

Examiner

RUIZ, AMANDA

Law office

O50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Atropos Health, Inc.

Representatives

Thomas Y. Yee Perkins Coie LLP

Technical classification

Nice Classes

Class 9Class 35Class 38Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable scientific and medical data via the internet

Class 35

Business consulting and management in the field of clinical trialsproviding information management services

Class 38

Providing access to an electronic exchange of health data and data analyses across an integrated nationwide clinical research network; transmission of database information and analyses of database information via telecommunications networks; electronic exchange of health data insights via telecommunication networks for analyses of health data from clinicianshealth systemsacademic medical centersothers

Class 42

Providing medicalhealthscientific research informationresearch dataresearch services to assist healthcare providers and healthcare professionals in making informed decisions for patient diagnosis and treatment; providing medical and scientific research information in the field of clinical trials; compiling data for research purposes in the field of medical science and medical consultancy; software as a service (SAAS) services featuring software for providing patients diagnosis and treatments for physicians for use in database management; software as a service (SAAS) services featuring software for collectingstoringindexinganalyzingupdatingmanagingsharingreporting clinical trial data to evaluate and determine medical diagnosis and treatments; software as a service (SAAS) services featuring software for searchingorganizing and managing datademographicsdiagnosesproceduresmedicationslaboratory valuesclinical notesmortalitylength of stay information for patients to inform clinical care decisions and research; software as a service (SAAS) services featuring software for providing healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms

Class 44

Providing medical information to healthcare providers and healthcare professionals to help them make informed decisions for patient diagnosis and treatment; providing tools to healthcare providers and healthcare professionals in the medical and patient-care industry to help them to assess clinical data for the purpose of patient diagnosis and treatment and improving quality of care in the medical and healthcare industryproviding tools in the nature of health assessment services; providing information and data related to patient datademographicsdiagnosesproceduresmedicationslaboratory valuesclinical notesmortalitylength of stay information for patients to inform clinical care decisions and research; providing on-line medical record analysis services designed to provide healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; providing on-line medical record analysis services designed to provide medical providers with custom tailored information about the outcomes for patients with similar symptoms and evidence needed for patient care decisions

Publications

History of USPTO decisions and trademark events.

35 publications found

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/16/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/15/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

07/15/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/24/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/25/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/25/2025

ALIE

ASSIGNED TO LIE

04/25/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/07/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

12/03/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

12/03/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/08/2024

GNRT

NON-FINAL ACTION E-MAILED

10/08/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

10/08/2024

EEXT

SOU TEAS EXTENSION RECEIVED

09/13/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/20/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/20/2024

IUAF

USE AMENDMENT FILED

06/25/2024

EISU

TEAS STATEMENT OF USE RECEIVED

06/25/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/19/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/23/2024

PUBO

PUBLISHED FOR OPPOSITION

01/23/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/20/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

12/20/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/20/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

12/20/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/20/2023

DOCK

ASSIGNED TO EXAMINER

12/18/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/01/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/01/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/01/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/01/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/14/2023

NWAP

NEW APPLICATION ENTERED

03/27/2023

Continuous trademark protection

Get notified about every new filing that threatens ATROPOS EVIDENCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.